Intelligence Platform

Patents

Browse 39 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 10016388

Ophthalmic lens, intraocular lens, and ophthalmic lens package having ophthalmic lens

HON HAI PRECISION INDUSTRY CO., LTD. · Granted Tue Jul 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9844530

Ophthalmic solutions for glaucoma and conjunctivitis treatment

AXIM BIOTECHNOLOGIES. INC. · Granted Tue Dec 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9814695

Ophthalmic solutions for glaucoma and conjunctivitis treatment

AXIM BIOTECHNOLOGIES. INC. · Granted Tue Nov 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9804298

Ophthalmic lens material

HON HAI PRECISION INDUSTRY CO., LTD. · Granted Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9801813

Preservative-free ophthalmic pharmaceutical formulation

SENTISS PHARMA PRIVATE LIMITED · Granted Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9709703

Ophthalmic lens material, ophthalmic lens, and method for making the same

HON HAI PRECISION INDUSTRY CO., LTD. · Granted Tue Jul 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9017725

Topical drug delivery systems for ophthalmic use

AURINIA PHARMACEUTICALS INC. · Granted Tue Apr 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8945604

Ophthalmic device, and method of use thereof, for increasing ocular boundary lubrication

The Regents of the University of California · Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8785393

Ophthalmic pharmaceutical compositions of DP2 receptor antagonists

Panmira Pharmaceuticals, LLC · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8679557

Synergistic herbal ophthalmic formulation for lowering the intra ocular pressure in case o

SENTISS PHARMA PRIVATE LIMITED · Granted Tue Mar 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8563028

Ophthalmic device, and method of use thereof, for increasing ocular boundary lubrication

The Regents of the University of California · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8529907

Methods of treating ophthalmic disorders

TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Tue Sep 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8153156

Hydrogel nanocompsites for ophthalmic applications

The United States of America as represented by the Department of Veteran Affairs · Granted Tue Apr 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7531173

Ophthalmic composition of a VEGF antagonist

REGENERON PHARMACEUTICALS, INC. · Granted Tue May 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 6531120

Ophthalmic histamine compositions and uses thereof

Maxim Pharmaceuticals, Inc. · Granted Tue Mar 11 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired